SCHEMBL6480217

SCHEMBL6480217

[CH2]c1c(CF)nn2ccccc12

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR P00533 2/20 0.35
ADORA2A P29274 2/20 0.34
ADORA1 P30542 2/20 0.34
RAF1 P04049 1/20 0.34
ADORA3 P0DMS8 1/20 0.34
ADORA2B P29275 1/20 0.34
GSK3B P49841 1/20 0.34
MAPK14 Q16539 1/20 0.34
MIF P14174 2/20 0.33
DRD2 P14416 2/20 0.33
DRD4 P21917 2/20 0.33
DRD3 P35462 2/20 0.33
PDE5A O76074 3/20 0.33
PDE3A Q14432 2/20 0.33
PDE4B Q07343 2/20 0.33
MEN1 O00255 1/20 0.33
ALDH1A1 P00352 1/20 0.33
CYP1A2 P05177 1/20 0.33
CYP3A4 P08684 1/20 0.33
CYP2D6 P10635 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6489300 0.82 DRD4 (0.38) EGFRADORA2AADORA1RAF1ADORA3
SCHEMBL6480221 0.79 MIF (0.36) EGFRADORA2AADORA1RAF1ADORA3
SCHEMBL6629042 0.75 EGFR (0.35) EGFRADORA2AADORA1RAF1ADORA3
SCHEMBL6490723 0.72 PDE5A (0.41) EGFRADORA2AADORA1RAF1ADORA3
SCHEMBL6494091 0.68 PDE5A (0.36) EGFRADORA2AADORA1RAF1ADORA3
SCHEMBL6489453 0.68 PDE4B (0.56) EGFRADORA2AADORA1RAF1ADORA3
SCHEMBL6491054 0.67 PDE4B (0.44) EGFRDRD2DRD4DRD3PDE3A
SCHEMBL23382438 0.66 HDAC1 (0.46) EGFRADORA2AADORA1MIFDRD2
SCHEMBL6489306 0.66 DRD2 (0.39) EGFRADORA2AADORA1MIFDRD2
SCHEMBL22168371 0.64 EGFR (0.38) EGFRADORA2AADORA1RAF1ADORA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6962938-B2 Spiro-cyclic β-amino acid derivatives as inhibitors of matrix metalloproteases and TNF-α converting enzyme (TACE) BRISTOL-MYERS SQUIBB PHARMA COMPANY (US) 2005-11-08 US disclosed
US-6720329-B2 ANTIINFLAMMATORY AGENTS BRISTOL-MYERS SQUIBB PHARMA 2004-04-13 US disclosed
EP-1373199-A4 SPIRO-CYCLIC BETA-AMINO ACID DERIVATIVES AS INHIBITORS OF MATRIX METALLOPROTEINASES AND TNF-ALPHA CONVERTING ENZYME (TAGE) BRISTOL MYERS SQUIBB PHARMA CO (US) 2004-04-07 EP disclosed
EP-1373199-A2 SPIRO-CYCLIC BETA-AMINO ACID DERIVATIVES AS INHIBITORS OF MATRIX METALLOPROTEINASES AND TNF-ALPHA CONVERTING ENZYME (TAGE) Bristol-Myers Squibb Pharma Company (US) 2004-01-02 EP disclosed
WO-2002074738-A2 SPIRO-CYCLIC BETA-AMINO ACID DERIVATIVES AS INHIBITORS OF MATRIX METALLOPROTEINASES AND TNF-ALPHA CONVERTING ENZYME (TAGE) BRISTOL-MYERS SQUIBB COMPANY (US) 2002-09-26 WO disclosed